Stockreport

Institutional investors in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) lost 25% last week but have reaped the benefits of longer-term growth [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF A total of 8 investors have a majority stake in the company with 53% ownership Insiders have sold recently If you want to know who really controls Y-mAbs Therapeuti [Read more]